222 related articles for article (PubMed ID: 12974985)
1. The safety of clozapine in the treatment of first- and multiple-episode patients with treatment-resistant schizophrenia.
Hofer A; Hummer M; Kemmler G; Kurz M; Kurzthaler I; Fleischhacker WW
Int J Neuropsychopharmacol; 2003 Sep; 6(3):201-6. PubMed ID: 12974985
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
[TBL] [Abstract][Full Text] [Related]
3. Early use of clozapine for poorly responding first-episode psychosis.
Agid O; Remington G; Kapur S; Arenovich T; Zipursky RB
J Clin Psychopharmacol; 2007 Aug; 27(4):369-73. PubMed ID: 17632221
[TBL] [Abstract][Full Text] [Related]
4. Ziprasidone vs clozapine in schizophrenia patients refractory to multiple antipsychotic treatments: the MOZART study.
Sacchetti E; Galluzzo A; Valsecchi P; Romeo F; Gorini B; Warrington L;
Schizophr Res; 2009 May; 110(1-3):80-9. PubMed ID: 19269791
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment.
Vayısoğlu S; Anıl Yağcıoğlu AE; Yağcıoğlu S; Karahan S; Karcı O; Gürel SC; Yazıcı MK
Schizophr Res; 2013 Jan; 143(1):207-14. PubMed ID: 23217729
[TBL] [Abstract][Full Text] [Related]
6. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
[TBL] [Abstract][Full Text] [Related]
7. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
[TBL] [Abstract][Full Text] [Related]
9. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
[TBL] [Abstract][Full Text] [Related]
10. Clozapine as a first treatment for schizophrenia.
Woerner MG; Robinson DG; Alvir JM; Sheitman BB; Lieberman JA; Kane JM
Am J Psychiatry; 2003 Aug; 160(8):1514-6. PubMed ID: 12900316
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of ziprasidone versus risperidone as augmentation in patients partially responsive to clozapine: a randomised controlled clinical trial.
Zink M; Kuwilsky A; Krumm B; Dressing H
J Psychopharmacol; 2009 May; 23(3):305-14. PubMed ID: 18562423
[TBL] [Abstract][Full Text] [Related]
12. Management of treatment-resistant patients with schizophrenia.
Marder SR
J Clin Psychiatry; 1996; 57 Suppl 11():26-30. PubMed ID: 8941168
[TBL] [Abstract][Full Text] [Related]
13. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
[TBL] [Abstract][Full Text] [Related]
16. Subjective response and attitudes toward antipsychotic drug therapy during the initial treatment period: a prospective follow-up study in patients with schizophrenia.
Hofer A; Rettenbacher MA; Edlinger M; Kemmler G; Widschwendter CG; Fleischhacker WW
Acta Psychiatr Scand; 2007 Nov; 116(5):354-61. PubMed ID: 17868428
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
[TBL] [Abstract][Full Text] [Related]
18. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
Mercier C; Bret P; Bret MC; Queuille E
Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
[TBL] [Abstract][Full Text] [Related]
19. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
[TBL] [Abstract][Full Text] [Related]
20. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
Pickar D; Bartko JJ
Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
